Dalrada Financial Corp Acquires Pacific Stem Cells, International Health Group and Stake in CHP Industrial Solutions
December 28, 2020
Dalrada Financial Corporation (through subsidiaries Dalrada Health Products and Dalrada Precision) announced letters of intent to acquire 100% of Pacific Stem Cells, LLC and International Health Group, Inc., and has purchased a stake in CHP Industrial Solutions (Malaysia). The deals expand Dalrada's healthcare services and training capabilities while adding precision CNC and custom part manufacturing capacity in Malaysia to support growth into new verticals and geographies.
- Buyers
- Dalrada Financial Corporation, Dalrada Health Products, Dalrada Precision
- Targets
- Pacific Stem Cells, LLC, International Health Group, Inc., CHP Industrial Solutions
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Johnson & Johnson Completes Acquisition of Halda Therapeutics for $3.05 Billion
December 29, 2025
Healthcare Services
Johnson & Johnson completed its acquisition of Halda Therapeutics OpCo, Inc. for $3.05 billion in cash. The deal brings Halda’s proprietary RIPTAC platform and its clinical-stage prostate cancer therapy HLD-0915, along with earlier-stage RIPTAC candidates for other solid tumors, into J&J’s oncology portfolio.
-
QHP Capital Acquires Applied StemCell
October 9, 2023
Biotechnology
QHP Capital has acquired Applied StemCell, a Milpitas, California–based cell and gene therapy CRO/CDMO that provides iPSC and TARGATT gene‑editing platforms for biopharma and research clients. QHP said the acquisition will provide strategic capital and operating support to accelerate ASC's commercial expansion and scale its manufacturing and service capabilities for the cell and gene therapy market.
-
Columbia Pacific Capital Partners Invests in Panacea Healthcare Solutions; Panacea Acquires Holliday & Associates and First Healthcare Compliance
August 26, 2022
Healthcare Services
Columbia Pacific Capital Partners (CPCP) has partnered with Panacea Healthcare Solutions to support Panacea's next stage of growth. With CPCP's investment, Panacea has simultaneously acquired Holliday & Associates and First Healthcare Compliance to expand its chargemaster, pricing transparency, compliance, and mid-revenue cycle software and services for hospitals, health systems, and physician practices.
-
Dalrada Corporation Acquires Watson Rx Solutions, Inc.
June 8, 2022
Healthcare Services
Dalrada Corporation (OTCQB: DFCO) has acquired Watson Rx Solutions, Inc., a 10-year-old pharmacy, to expand its Dalrada Health subsidiary and build an end-to-end healthcare offering that includes pharmacy services. The acquisition is intended to enhance Dalrada's ability to provide prescription processing alongside its clinics, telemedicine, testing facilities and other healthcare technologies.
-
Dalrada Health (Sòlas) Acquires Remedi Med Spas
April 12, 2022
Healthcare Services
Dalrada Corporation's Dalrada Health division, operating under the Sòlas Rejuvenation + Wellness group, acquired Remedi Med Spas and its two Southern California locations in Coronado and Mission Hills from Dr. Rakhesh Guttikonda. The acquisition adds two clinics and staff to the North San Diego–based Sòlas platform as part of its regional expansion of wellness and aesthetic services.
-
Midatech Pharma to Acquire DARA BioSciences
June 4, 2015
Pharmaceuticals
Midatech Pharma PLC entered into a merger agreement to acquire DARA BioSciences, with DARA shareholders receiving Midatech ordinary shares via ADRs and a contingent value right (CVR). The deal gives Midatech a U.S. commercial footprint and an expanded oncology supportive-care portfolio; closing was expected in Q3/Q4 2015 subject to customary conditions and ADR listing.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.